PURPOSE: Lennox-Gastaut syndrome (LGS) is a severe epileptic encephalopathy with complex etiology. To explore possible genetic predispositions and causes of LGS, we have searched for copy number variants (CNVs). METHODS: We studied 21 patients with LGS or LGS-like epilepsy for CNVs using whole-genome array comparative genomic hybridization (aCGH). KEY FINDINGS: Eight patients (38%) carried rare CNVs that might contribute to their phenotype. The pathogenicity could be questioned in some of them, but in four patients (19%) a causative role was considered highly probable. Three had CNVs and clinical features consistent with known genetic syndromes: 22q13.3 deletion, 2q23.1 deletion, and MECP2 duplication. SIGNIFICANCE: There is a high frequency of rare CNVs in adult patients with LGS-like epilepsy. The phenotypes of these background disorders may be obscured by the effects of intractable seizures and massive antiepileptic drug treatment. Previously, syndromic disorders were primarily identified by their clinical features; however, a genome wide approach with identification of the genotype might shed light on the phenotype.
PURPOSE:Lennox-Gastaut syndrome (LGS) is a severe epileptic encephalopathy with complex etiology. To explore possible genetic predispositions and causes of LGS, we have searched for copy number variants (CNVs). METHODS: We studied 21 patients with LGS or LGS-like epilepsy for CNVs using whole-genome array comparative genomic hybridization (aCGH). KEY FINDINGS: Eight patients (38%) carried rare CNVs that might contribute to their phenotype. The pathogenicity could be questioned in some of them, but in four patients (19%) a causative role was considered highly probable. Three had CNVs and clinical features consistent with known genetic syndromes: 22q13.3 deletion, 2q23.1 deletion, and MECP2 duplication. SIGNIFICANCE: There is a high frequency of rare CNVs in adult patients with LGS-like epilepsy. The phenotypes of these background disorders may be obscured by the effects of intractable seizures and massive antiepileptic drug treatment. Previously, syndromic disorders were primarily identified by their clinical features; however, a genome wide approach with identification of the genotype might shed light on the phenotype.
Authors: Arvid Suls; Johanna A Jaehn; Angela Kecskés; Yvonne Weber; Sarah Weckhuysen; Dana C Craiu; Aleksandra Siekierska; Tania Djémié; Tatiana Afrikanova; Padhraig Gormley; Sarah von Spiczak; Gerhard Kluger; Catrinel M Iliescu; Tiina Talvik; Inga Talvik; Cihan Meral; Hande S Caglayan; Beatriz G Giraldez; José Serratosa; Johannes R Lemke; Dorota Hoffman-Zacharska; Elzbieta Szczepanik; Nina Barisic; Vladimir Komarek; Helle Hjalgrim; Rikke S Møller; Tarja Linnankivi; Petia Dimova; Pasquale Striano; Federico Zara; Carla Marini; Renzo Guerrini; Christel Depienne; Stéphanie Baulac; Gregor Kuhlenbäumer; Alexander D Crawford; Anna-Elina Lehesjoki; Peter A M de Witte; Aarno Palotie; Holger Lerche; Camila V Esguerra; Peter De Jonghe; Ingo Helbig Journal: Am J Hum Genet Date: 2013-10-24 Impact factor: 11.025
Authors: Rhys H Thomas; Lin Mei Zhang; Gemma L Carvill; John S Archer; Sinéad B Heavin; Simone A Mandelstam; Dana Craiu; Samuel F Berkovic; Deepak S Gill; Heather C Mefford; Ingrid E Scheffer Journal: Neurology Date: 2015-02-11 Impact factor: 9.910
Authors: Dana Marafi; Bernhard Suter; Rebecca Schultz; Daniel Glaze; Valory N Pavlik; Alica M Goldman Journal: Neurology Date: 2018-12-14 Impact factor: 9.910
Authors: Elizabeth C Galizia; Candace T Myers; Costin Leu; Carolien G F de Kovel; Tatiana Afrikanova; Maria Lorena Cordero-Maldonado; Teresa G Martins; Maxime Jacmin; Suzanne Drury; V Krishna Chinthapalli; Hiltrud Muhle; Manuela Pendziwiat; Thomas Sander; Ann-Kathrin Ruppert; Rikke S Møller; Holger Thiele; Roland Krause; Julian Schubert; Anna-Elina Lehesjoki; Peter Nürnberg; Holger Lerche; Aarno Palotie; Antonietta Coppola; Salvatore Striano; Luigi Del Gaudio; Christopher Boustred; Amy L Schneider; Nicholas Lench; Bosanka Jocic-Jakubi; Athanasios Covanis; Giuseppe Capovilla; Pierangelo Veggiotti; Marta Piccioli; Pasquale Parisi; Laura Cantonetti; Lynette G Sadleir; Saul A Mullen; Samuel F Berkovic; Ulrich Stephani; Ingo Helbig; Alexander D Crawford; Camila V Esguerra; Dorothee G A Kasteleijn-Nolst Trenité; Bobby P C Koeleman; Heather C Mefford; Ingrid E Scheffer; Sanjay M Sisodiya Journal: Brain Date: 2015-03-17 Impact factor: 13.501
Authors: Daniel Ta; Jenny Downs; Gareth Baynam; Andrew Wilson; Peter Richmond; Helen Leonard Journal: Orphanet J Rare Dis Date: 2022-03-21 Impact factor: 4.123